From: The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
Genotype
CAD patients
Hypertensive patients
Control population
P
PlA1/A1
70.4
67.8
72
0.79
PlA1/A2
27
29.1
25
0.91
PlA2/A2
2.6
3.1
3
0.81